The Accrual to Clinical Trials (ACT) Network is a real-time platform for researchers to explore and validate the feasibility for clinical studies across the NCATS Clinical and Translational Science Award consortium. ACT helps researchers design and complete clinical studies and is secure, HIPAA-compliant and IRB-approved.
ACT was developed collaboratively by members of NCATS’ Clinical and Translational Science Award consortium, with funding from the NIH National Center for Advancing Translational Sciences.
With the ACT Network, researchers can:
- Explore patient populations: Learn about a patient population in-depth and in real-time from their computer.
- Check the feasibility of clinical studies: Iteratively test and refine inclusion and exclusion criteria to confirm the feasibility of a clinical study.
- Find partner sites: Search for patients across the CTSA network to identify potential partners for multi-site studies.
- Demonstrate feasibility: Access easy-to-download results for use in funding proposals and IRB submissions to demonstrate the feasibility of a clinical study.